UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 526

Sortiert nach

Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR -Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance

Cancers, 2019-07, Vol.11 (7), p.923

2019

Volltextzugriff (PDF)

Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK -Rearranged NSCLC: ALK - and BRAF -Mutations Followed by Epithelial-Mesenchymal Transition

International journal of molecular sciences, 2020-04, Vol.21 (8), p.2847

2020

Volltextzugriff (PDF)

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC

International journal of molecular sciences, 2023-08, Vol.24 (17), p.13077

2023

Volltextzugriff (PDF)

Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma

The Journal of molecular diagnostics : JMD, 2014-07, Vol.16 (4), p.418-430

2014

Volltextzugriff (PDF)

The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking

Histopathology, 2017-05, Vol.70 (6), p.889-895

2017

Volltextzugriff (PDF)

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation

Lung cancer (Amsterdam, Netherlands), 2017-11, Vol.113, p.14-17

2017

Volltextzugriff (PDF)

Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas

TheScientificWorld, 2012-01, Vol.2012, p.170496-4

2012

Volltextzugriff (PDF)

Endobronchial metastases from extrapulmonary solid tumors

Acta oncologica, 2004-01, Vol.43 (1), p.73-79

Sørensen, Jens B.

2004

Volltextzugriff (PDF)

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer

Histopathology, 2014-02, Vol.64 (3), p.412-420

2014

Volltextzugriff (PDF)

Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression

BMC cancer, 2009-01, Vol.9 (1), p.25-25, Article 25

2009

Volltextzugriff (PDF)

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.47-53

2014

Volltextzugriff (PDF)

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease

Journal of internal medicine, 1995-08, Vol.238 (2), p.97-110

1995

Volltextzugriff (PDF)

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo IMET/I Amplification in Patients with Metastatic IEGFR/I-Mutated NSCLC

International journal of molecular sciences, 2023-08, Vol.24 (17)

2023

Volltextzugriff (PDF)

Differences in RRM 1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non‐small‐cell lung cancer

Histopathology, 2014-02, Vol.64 (3), p.412-420

2014

Volltextzugriff (PDF)

Abstract 2276: High frequency of pathogenic germline variants in patients with malignant mesothelioma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2276-2276

2022

Volltextzugriff (PDF)

Abstract 3556: Diagnostic potential of microRNAs (miRs) in malignant pleural mesothelioma (MPM)

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3556-3556

2013

Volltextzugriff (PDF)

Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma

Medical oncology (Northwood, London, England), 2015-02, Vol.32 (2), p.458, Article 11

2015

Volltextzugriff (PDF)

P1-150: Phase II study of Carboplatin and Vinorelbine (i.v. and orally) first line chemotherapy in non-resectable Malignant Pleural Mesothelioma (MPM)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S610-S611

2007

Volltextzugriff (PDF)

Metastatic Pattern at Autopsy in non-resectable Adenocarcinoma of the Lung: A Study from a Cohort of 259 Consecutive Patients Treated with Chemotherapy

Acta oncologica, 1997, Vol.36 (3), p.301-306

1997

Volltextzugriff (PDF)

P1-149: Cisplatin and i.v. Vinorelbine first line chemotherapy in non-resectable Malignant Pleural Mesothelioma (MPM)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S610-S610

2007

Volltextzugriff (PDF)

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

Annals of oncology, 2011-07, Vol.22 (7), p.1507-1519

2011

Volltextzugriff (PDF)

P1-091: Preoperative staging procedures using 18F-FDG-Positron Emission Tomography-Computed Tomography fused imaging (PET-CT-Scan) and Mediastinoscopy compared to Surgical-Pathological findings in Malignant Pleural Mesothelioma undergoing Extrapleural Pneumonectomy

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S586-S586

2007

Volltextzugriff (PDF)

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1973-1980

2011

Volltextzugriff (PDF)

1 – 25 von 526

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(471)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(401)
Life Sciences & Biomedicine
(356)
Humans
(273)
Female
(184)
Male
(166)
Middle Aged
(135)
Biological And Medical Sciences
(124)
Adult
(120)
Aged
(105)
Medical Sciences
(93)
Animals
(68)
Oncology
(62)
Cardiovascular System & Cardiology
(39)
Time Factors
(37)
Prognosis
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)
Physical Sciences
(34)
Surgery
(34)
Neurosciences & Neurology
(33)
Medicin Och Hälsovetenskap
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR -Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance

Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK -Rearranged NSCLC: ALK - and BRAF -Mutations Followed by Epithelial-Mesenchymal Transition

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC

Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma

The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas

Endobronchial metastases from extrapulmonary solid tumors

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer

Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo IMET/I Amplification in Patients with Metastatic IEGFR/I-Mutated NSCLC

Differences in RRM 1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non‐small‐cell lung cancer

Abstract 2276: High frequency of pathogenic germline variants in patients with malignant mesothelioma

Abstract 3556: Diagnostic potential of microRNAs (miRs) in malignant pleural mesothelioma (MPM)

Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma

P1-150: Phase II study of Carboplatin and Vinorelbine (i.v. and orally) first line chemotherapy in non-resectable Malignant Pleural Mesothelioma (MPM)

Metastatic Pattern at Autopsy in non-resectable Adenocarcinoma of the Lung: A Study from a Cohort of 259 Consecutive Patients Treated with Chemotherapy

P1-149: Cisplatin and i.v. Vinorelbine first line chemotherapy in non-resectable Malignant Pleural Mesothelioma (MPM)

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

P1-091: Preoperative staging procedures using 18F-FDG-Positron Emission Tomography-Computed Tomography fused imaging (PET-CT-Scan) and Mediastinoscopy compared to Surgical-Pathological findings in Malignant Pleural Mesothelioma undergoing Extrapleural Pneumonectomy

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Suchergebnisse filtern